New Protein Target Could Help Treat Pancreatic Cancer
Researchers identified a protein that helps pancreatic tumors survive, a finding currently limited to mouse models.
Updated on Oct. 30, 2026 in Cancer
Live Poll
Are recent advances in cancer research making effective new treatments significantly more likely for patients?
Researchers have identified the protein ANO6 as a potential therapeutic target for pancreatic ductal adenocarcinoma. By blocking this protein, investigators reduced tumor growth and immune suppression in mouse models, offering a new potential approach for future treatment strategies.
Why it matters
Pancreatic tumors often lack functional blood vessels and rely on alternative nutrient sources, such as cholesterol, to survive. This research highlights how targeting specific cellular pathways can starve tumors and potentially restore immune function in the tumor environment.
This preclinical study in mouse models identified two mechanisms by which ANO6 supports tumor survival. While initial results show promise in reducing tumor weight, the findings remain preliminary and require further investigation to determine if they translate to human treatment.
The players
Fox Chase Cancer Center
A research institution focused on cancer treatment and prevention that conducted the study.
University of Pennsylvania
A research university where study co-author Serge Fuchs holds an academic appointment.
Serge Fuchs
A researcher at the University of Pennsylvania who co-authored the study on pancreatic cancer.
The details
Cancer cells survive in nutrient-poor environments by using a process called trogocytosis, where they essentially nibble lipids and cholesterol directly from surrounding cancer-associated fibroblasts. The ANO6 protein is essential for preparing fibroblast membranes for this transfer. By facilitating this lipid acquisition, ANO6 both fuels cancer cell growth and indirectly suppresses the immune system by causing cytotoxic T lymphocytes to lose their own cholesterol supply, leading to T-cell exhaustion.
Timeline
• October 30, 2026: Research findings on the ANO6 protein were published in Nature Cancer.
Health Landscape
This research builds upon the growing field of fibroblast-targeted cancer therapies by identifying a specific protein involved in lipid transfer. It adds to the ongoing effort to overcome the metabolic barriers that make pancreatic cancer uniquely difficult to treat with conventional drugs.
This preclinical study in mice does not currently change standard treatment options for patients with pancreatic cancer. These findings are foundational research; any questions about clinical trials or experimental therapies should be directed to your oncologist.
The takeaway
Pancreatic cancer cells rely on specific proteins to steal nutrients from nearby cells to fuel their own growth. Understanding this process of nutrient acquisition could lead to new ways to weaken tumors in the future, though patients should consult their medical team for current evidence-based care.
Further reading
For more on the latest research in oncology, visit our Cancer section.
Live Poll
Are recent advances in cancer research making effective new treatments significantly more likely for patients?
